Guillaume P.
- Country
- France
- Department
- Digestive and oncological surgery
Research Overview
- Phase II Study of Dostarlimab-Based Immunotherapy in Localized dMMR/MSI-H Esophagogastric Junction and Gastric Adenocarcinoma
- NEoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)
- Phase III Multicentric Study on Chemotherapy Efficacy in Stage III Colorectal Cancer with Positive ctDNA Post-Surgery Using Irinotecan and Drug Combination
Data & Insights
Has run more than one trial at 108 of 243 partner sites.
Specializations
Colorectal Cancer Innovation
The investigator specializes in advanced approaches for colorectal cancer treatment, with particular focus on surgical techniques and post-operative care. Their research encompasses anastomotic perfusion assessment and innovative applications of fluorescence angiography in surgical procedures.
- Surgical perfusion techniques
- Circulating tumor DNA analysis
- Preoperative treatment strategies
Gastric Cancer Research
Expertise in gastroesophageal cancer management with emphasis on perioperative treatment protocols. The investigator explores immunotherapy applications and treatment de-escalation strategies for specific patient populations.
- Perioperative immunotherapy
- Surgical resection techniques
- Treatment optimization protocols
Surgical Oncology Advancement
Focus on developing innovative surgical approaches for digestive cancers, including the investigation of perioperative interventions and post-surgical complication prevention strategies.
- Minimally invasive techniques
- Post-operative recovery optimization
- Surgical complication prevention
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.